DrugDashboards
← Home
Manufacturing facility

B. Braun US Pharmaceutical Manufacturing LLC

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
2525 McGaw Avenue, Irvine, California (CA) 92614, United States (USA)
Operations here
analysislabelmanufacturepacksterilize
FDA identifiers
FEI 2021236 · DUNS 037425308

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 5 drugs, 1 already in shortage. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-11-21
  • NAIBlood and Blood Products2024-08-06
  • VAIDrug Quality Assurance2023-12-15
  • VAIDrug Quality Assurance2021-08-17
  • OAIDrug Quality Assurance2018-06-29
  • OAIDrug Quality Assurance2016-05-11
  • VAIDrug Quality Assurance2015-03-03
  • VAIDrug Quality Assurance2014-02-13
  • VAIDrug Quality Assurance2013-11-13
  • VAIDrug Quality Assurance2013-05-17
  • VAIDrug Quality Assurance2012-03-08
  • NAIDrug Quality Assurance2011-03-21
  • NAIDrug Quality Assurance2010-09-22
  • VAIDrug Quality Assurance2009-03-05

Drugs this plant is listed as making

5 distinct drugs across 8 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.